Contribution of Auriculotherapy in the Management of Mastectomy With Immediate Reconstruction by Latissimus Dorsi Flap (ATMAGD)

Sponsor
Ramsay Générale de Santé (Other)
Overall Status
Terminated
CT.gov ID
NCT05126615
Collaborator
(none)
10
1
2
28.3
0.4

Study Details

Study Description

Brief Summary

Over the past decade, more and more healthcare professionals are using auriculotherapy as a preventative and effective therapy for pain. This therapy is applied by odontologists, anesthetists, surgeons, etc., to alleviate chronic pain. The effects of auriculotherapy are known in particular in reducing preoperative anxiety, pain in cancer patients and postoperative pain.

The aim of this study is to assess the effectiveness of adding auriculotherapy to the standard global anesthetic protocol, compared to this single reference protocol, on the incidence at 3 months post-intervention of Chronic Post-Surgical Pain, in patients operated for a mastectomy with reconstruction immediate by latissimus dorsi flap.

Condition or Disease Intervention/Treatment Phase
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
10 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Supportive Care
Official Title:
Contribution of Auriculotherapy in the Management of Mastectomy With Immediate Reconstruction by Latissimus Dorsi Flap (ATMAGD)
Actual Study Start Date :
May 10, 2019
Actual Primary Completion Date :
Aug 6, 2021
Actual Study Completion Date :
Sep 17, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Patients with auriculotherapy

Mastectomy operated patient then, auriculotherapy

Drug: Auriculotherapy
Application of a bolus of 5 μ of liquid nitrogen via a cryospray on the auriculotherapy points A4, C18, D9, C9, DIX, H13, G14 and FXVII, chosen according to a neurophysiological reasoning taking into account the surgical intervention performed and innervation of the anatomical region affected by the intervention.

Behavioral: Chronic Post-Surgical Pain evaluation
Different questionnaires : BPI : Brief Pain Inventory DN4

Placebo Comparator: Patient with placebo

Mastectomy operated patient then, they received placebo

Behavioral: Chronic Post-Surgical Pain evaluation
Different questionnaires : BPI : Brief Pain Inventory DN4

Outcome Measures

Primary Outcome Measures

  1. Presence, or not, of Chronic Post-Surgical Pain (DCPC) [3 months]

    DCPC noted during the clinical examination of the 3rd postoperative month : - score obtained at BPI : Brief Pain Inventory (9 items : many items with answers between 0 and 10)

  2. Presence, or not, of Chronic Post-Surgical Pain (DCPC) [3 months]

    DCPC noted during the clinical examination of the 3rd postoperative month : - score obtained at DN4 (neuropathic pain) : 4 different items

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Women patient over 18 years-old

  • Patient scheduled for a mastectomy with immediate reconstruction by latissimus dorsi flap with or without symmetrization on the contralateral breast.

  • Patient affiliated or beneficiary of a social security scheme.

  • Patient who has given her free and informed consent.

  • Preoperative blood test showing no contraindication to the operation.

Exclusion Criteria:
  • Refusal of the patient.

  • No indication for auriculotherapy:

  • Patient having a heavy treatment with neuroleptics,

  • Or tricyclic antidepressants which interfere with the action of auriculotherapy.

  • Patient undergoing long-term morphine treatment for chronic pain.

  • Patient with unweaned opioid addiction.

  • Chronic painful patient.

  • Protected patient: Major under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision; Hospitalized without consent.

  • Pregnant, breastfeeding or parturient woman.

  • Patient participating in another interventional study.

  • Patient who had already participated in this study as part of first breast surgery.

  • Patient receiving regular care by auriculotherapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 Hôpital Privé Paul d'Egine Champigny-sur-Marne France 94500

Sponsors and Collaborators

  • Ramsay Générale de Santé

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ramsay Générale de Santé
ClinicalTrials.gov Identifier:
NCT05126615
Other Study ID Numbers:
  • 2018-A01108-47
First Posted:
Nov 19, 2021
Last Update Posted:
Nov 19, 2021
Last Verified:
Nov 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Nov 19, 2021